H. Lundbeck A — Director's Dealing 2008

Mar 7, 2008

Announcement of transactions with shares and linked securities in H. Lundbeck A/S made by executives and their closely associated persons and legal entities

Announcement of transactions with shares and linked securities in H. Lundbeck A/S made by executives and their closely associated persons and legal entities

H. Lundbeck A/S hereby reports transactions made by executives and persons and legal entities closely associated to them with shares in H. Lundbeck A/S and linked securities, cf. section 28a of the Danish Securities Trading Act.

The list is based on reports received by H. Lundbeck A/S from the company's executives today or yesterday.

Name:	Jes Østergaard
Job position of the executive:	Member of Supervisory Board
Relation to executive (associated person or legal entity):
ID code (ISIN code):	DK 0010287234
Description of the security:	Share
Nature of the transaction:	Purchase of shares
Date of trading:	6 March 2008
Market on which the trading was effected:	Copenhagen Stock Exchange
Number of traded securities:	500	pcs.
Market price of securities traded:	53,324.22	DKK

Name:	Kim Rosenville Christensen
Job position of the executive:	Member of Supervisory Board
Relation to executive (associated person or legal entity):
ID code (ISIN code):	DK 0010287234
Description of the security:	Share
Nature of the transaction:	Purchase of shares
Date of trading:	6 March 2008
Market on which the trading was effected:	Copenhagen Stock Exchange
Number of traded securities:	500	pcs.
Market price of securities traded:	53,649.38	DKK

Persons/entities under an obligation to report

Persons or entities under an obligation to report are defined as members of the Executive Management and the Supervisory Board of H. Lundbeck A/S and persons/entities closely associated to them.

Closely associated persons/entities means inter alia:

• spouse or cohabitant

• children below the age of 18

• legal entities in which the insider has a controlling influence

The content of this release will have no influence on the Lundbeck Group's financial result for 2008.

Stock Exchange Release No 329 - 7 March 2008

About Lundbeck

H. Lundbeck A/S is an international pharmaceutical company engaged in the research and development, production, marketing and sale of drugs for the treatment of psychiatric and neurological disorders. In 2007, the company's revenue was DKK 11 billion (approximately EUR 1.5 billion or USD 2.0 billion). The number of employees is approximately 5,300 globally. For further information, please visit www.lundbeck.com

Attachments:

• Release 329 in pdf format

  ---

  This content was distributed through

  

  - connecting communication professionals with their target audience. Visit us here.